World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 60 3281 3024 1527 1396 132 26774

Hyam I. Levitsky publications per year

The chart shows the history of publications by Hyam I. Levitsky between 1981 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Hyam I. Levitsky published across 45 years, from 1981 to 2025, averaging 3.3 papers a year. Output peaked at 11 publications in 2011. 4 of the 149 publications appeared in the last two years.

No. of publications
2 4 6 8 10
Bar chart. Horizontal axis: year, 1981 to 2025. Vertical axis: number of publications, 0 to 11. Peak 11 publications in 2011. 1981: 1 publication 1982: 0 publications 1983: 0 publications 1984: 0 publications 1985: 0 publications 1986: 0 publications 1987: 0 publications 1988: 0 publications 1989: 0 publications 1990: 1 publication 1991: 2 publications 1992: 1 publication 1993: 3 publications 1994: 5 publications 1995: 4 publications 1996: 8 publications 1997: 3 publications 1998: 8 publications 1999: 7 publications 2000: 5 publications 2001: 4 publications 2002: 1 publication 2003: 6 publications 2004: 5 publications 2005: 5 publications 2006: 8 publications 2007: 4 publications 2008: 4 publications 2009: 4 publications 2010: 4 publications 2011: 11 publications 2012: 3 publications 2013: 9 publications 2014: 4 publications 2015: 7 publications 2016: 3 publications 2017: 2 publications 2018: 1 publication 2019: 1 publication 2020: 0 publications 2021: 0 publications 2022: 0 publications 2023: 11 publications 2024: 3 publications 2025: 1 publication
1981 2025

149 publications in total across all disciplines

View publications per year as a table
Hyam I. Levitsky: publications per year, 1981 to 2025
Year Publications
1981 1
1982 0
1983 0
1984 0
1985 0
1986 0
1987 0
1988 0
1989 0
1990 1
1991 2
1992 1
1993 3
1994 5
1995 4
1996 8
1997 3
1998 8
1999 7
2000 5
2001 4
2002 1
2003 6
2004 5
2005 5
2006 8
2007 4
2008 4
2009 4
2010 4
2011 11
2012 3
2013 9
2014 4
2015 7
2016 3
2017 2
2018 1
2019 1
2020 0
2021 0
2022 0
2023 11
2024 3
2025 1
Total 149
Download as CSV

Hyam I. Levitsky publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Hyam I. Levitsky sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 132–141 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 132 publications — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160 132
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Hyam I. Levitsky D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Hyam I. Levitsky sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 60–61 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 60 D-Index — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197 60
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Hyam I. Levitsky is affiliated with Johns Hopkins University in the United States. Their recent research contributions focus predominantly on immunology and immune cell function, with a particular interest in the reproductive system and pregnancy-related immunological processes.

Their recent papers include the following:

  • Abstract 6802: CXCR4 transgene improves in vivo migration and efficacy of engineered iPSC-derived natural killer cells, 2024, Cancer Research
  • Abstract 1320: Engineered expression of HLA-E and HLA-G protects iPSC-derived cells from killing by primary NK cells, 2024, Cancer Research
  • Abstract 3613: Screening iPSC lines for optimal characteristics of differentiation into immune effector cells for clinical programs, 2024, Cancer Research
  • POS0058 GENERATION OF iPSC-DERIVED CAR-NK, γδ CAR-T, AND αβ CAR-T CELLS WITH POTENT ACTIVITY FOR TREATMENT OF B CELL-MEDIATED AUTOIMMUNE DISEASES, 2025, Annals of the Rheumatic Diseases

Levitsky frequently collaborates with a team of researchers, including:

  • Daniel J. Perry
  • Liam Campion
  • Buddha Gurung
  • Michael Naso
  • Barry Morse

Their work is primarily published in the venue Cancer Research, with multiple publications there, as well as in Annals of the Rheumatic Diseases.

Levitsky's research spans the subfield of immunology, with their work emphasizing:

  • Immune cell function and interaction
  • Reproductive system and pregnancy

Best Publications

  • Vaccination with Irradiated Tumor Cells Engineered to Secrete Murine Granulocyte-Macrophage Colony-Stimulating Factor Stimulates Potent, Specific, and Long-Lasting Anti-Tumor Immunity

    Glenn Dranoff;Elizabeth Jaffee;Audrey Lazenby;Paul Golumbek

  • The Central Role of CD4+ T Cells in the Antitumor Immune Response

    Kenneth Hung;Robert Hayashi;Anne Lafond-Walker;Charles Lowenstein

  • Role of LAG-3 in regulatory T cells.

    Ching Tai Huang;Creg J. Workman;Dallas Flies;Xiaoyu Pan

  • Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

    Alex Y. C. Huang;Paul Golumbek;Mojgan Ahmadzadeh;Elizabeth Jaffee

  • Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy

    Carola H. Ries;Michael A. Cannarile;Sabine Hoves;Jörg Benz

  • Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

    Eric R. Fearon;Drew M. Pardoll;Toshiuki Itaya;Paul Golumbek

  • Treatment of Established Tumors with a Novel Vaccine That Enhances Major Histocompatibility Class II Presentation of Tumor Antigen

    Ken Yu Lin;Frank G. Guarnieri;Kevin F. Staveley-O'Carroll;Hyam I. Levitsky

  • Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4

    Paul T. Golumbek;Audrey J. Lazenby;Hyam I. Levitsky;Liz M. Jaffee

  • Induction of antigen-specific T cell anergy: An early event in the course of tumor progression

    Kevin Staveley-O’Carroll;Eduardo Sotomayor;Jami Montgomery;Ivan Borrello

  • Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer

    Jonathan W Simons;Bahar Mikhak;Ju-Fay Chang;Angelo M DeMarzo

  • Bioactivity of Autologous Irradiated Renal Cell Carcinoma Vaccines Generated by Ex Vivo Granulocyte-Macrophage Colony-Stimulating Factor Gene Transfer

    J.W. Simons;E.M. Jaffee;C.E. Weber;H.J. Levitsky

  • Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40.

    Eduardo M. Sotomayor;Ivan M Borrello;Erev Tubb;Frédérique Marie Rattis

  • High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.

    Leo Luznik;Javier Bolaños-Meade;Marianna Zahurak;Allen R. Chen

  • ENGINEERING AN INTRACELLULAR PATHWAY FOR MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II PRESENTATION OF ANTIGENS

    Tzyy-Choou Wu;F. G. Guarnieri;K. F. Staveley-O'carroll;R. P. Viscidi

  • Depleting tumor-specific Tregs at a single site eradicates disseminated tumors

    Aurélien Marabelle;Holbrook Kohrt;Idit Sagiv-Barfi;Bahareh Ajami

  • Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines.

    Gang Zhou;Charles G. Drake;Hyam I. Levitsky

  • Activation of low avidity CTL specific for a self epitope results in tumor rejection but not autoimmunity.

    David J. Morgan;Huub T. C. Kreuwel;Shonna Fleck;Hyam I. Levitsky

  • Cross-presentation of tumor antigens by bone marrow-derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression.

    Eduardo M. Sotomayor;Ivan Borrello;Frédérique Marie Rattis;Alex G. Cuenca

  • In Vivo Cross-Priming of MHC Class I–Restricted Antigens Requires the TAP Transporter

    Alex Y.C Huang;Allen T Bruce;Drew M Pardoll;Hyam I Levitsky

  • Cell polarity: an examination of its behavioral expression and its consequences for polymorphonuclear leukocyte chemotaxis.

    S H Zigmond;H I Levitsky;B J Kreel

Frequent Co-Authors

Elizabeth M. Jaffee
Elizabeth M. Jaffee Johns Hopkins University
Drew M. Pardoll
Drew M. Pardoll Johns Hopkins University School of Medicine
Richard J. Jones
Richard J. Jones Johns Hopkins University
Leo Luznik
Leo Luznik Johns Hopkins University
Ephraim J. Fuchs
Ephraim J. Fuchs Johns Hopkins University
B. Douglas Smith
B. Douglas Smith Johns Hopkins University
Allan D. Hess
Allan D. Hess Johns Hopkins University
Fray F. Marshall
Fray F. Marshall Emory University
Richard C. Mulligan
Richard C. Mulligan Harvard University
William G. Nelson
William G. Nelson Johns Hopkins University School of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students pursuing Immunology in the USA, exploring related online degrees can open doors to diverse healthcare careers. Many professionals in the field transition into advanced nursing roles, where specialized knowledge is critical. For instance, understanding fnp to acnp bridge program online options can help Family Nurse Practitioners move into Acute Care Nurse Practitioner roles, expanding their scope of practice.

Accelerated pathways are also popular, allowing students to fast-track their nursing careers. Programs like accelerated nurse practitioner program provide a faster route to becoming a nurse practitioner, which can be advantageous for those seeking to combine clinical expertise with immunological insights.

For those without a nursing background, enrolling in online rn programs for non nurses offers an accessible entry point into the profession. These programs prepare students for registered nursing roles, which are critical in immunology-related healthcare settings.

Career potential is another key consideration. Salary expectations vary by state and specialty; understanding how much does a dnp make can guide decisions about further education and specialization in the immunology field. Aligning educational paths with career goals ensures both professional growth and financial reward.

Best Scientists Citing Hyam I. Levitsky

Trending Scientists

Recently Published Articles